Trade Cytek Biosciences Inc - CTKB
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. The company offers aurora and northern lights systems delivers cell analysis; aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; enhanced small particle detection; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. It serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. The company distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.Latest shares articles

Allianz stock forecast: record H1 profit, Q3 earnings ahead
Allianz is a German insurer whose shares are trading near record levels following record first-half operating profit and reports of a possible €5.8 billion acquisition of AA. Explore third-party ALV targets and technicals. Past performance is not a reliable indicator of future results.
13:26, 30 September 2026

Assicurazioni Generali stock forecast: rising bond yields, ECB outlook
Generali is an Italian insurer listed in Milan, with its shares recently trading amid rising eurozone bond yields and wider financial-sector activity in Italy. Explore third-party G price targets and technical analysis. Past performance is not a reliable indicator of future results.
07:38, 30 September 2026

Amplifon stock forecast: H1 growth and margin outlook
Amplifon is an Italian hearing-care company listed on Borsa Italiana. Its pending GN Hearing acquisition remains a key focus as investors assess potential effects on growth, margins and debt. Explore third-party AMP price targets. Past performance is not a reliable indicator of future results.
07:19, 30 September 2026

Uber Technologies stock forecast: 3,300 job cuts, robotaxi push
Uber is cutting around 3,300 jobs as part of a restructuring, while expanding its autonomous-vehicle partnerships amid growing competition in the robotaxi market. Explore third-party UBER price targets and technical analysis. Past performance is not a reliable indicator of future results.
13:42, 29 September 2026